Pub. Date : 2017 Dec 15
PMID : 29080795
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | PPARgamma agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARgamma/PTEN/Akt pathway. | Gefitinib | AKT serine/threonine kinase 1 | Homo sapiens |